Conning Portfolio holdings
Conning manages money mainly for insurance companies and pension plans, mostly in bonds and stocks. William S. Conning founded the firm in 1912 to give investment advice to high-net-worth individuals, and it began managing investments for insurers in 1983. Conning has grown by buying majority stakes in specialist managers, including Octagon Credit Investors, which focuses on loans and high yield bonds, in 2016, and the emerging markets debt manager Global Evolution, in which it became majority owner in 2020. It is part of Generali Investments, and its controlling shareholder is Generali Investments Holding, based in Italy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
IBM
IBM
|
+$35.1M |
| 2 |
General Dynamics
GD
|
+$35M |
| 3 |
Marathon Petroleum
MPC
|
+$7.95M |
| 4 |
Nucor
NUE
|
+$5.59M |
| 5 |
3M
MMM
|
+$5.56M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$37.3M |
| 2 |
Emerson Electric
EMR
|
+$37.2M |
| 3 |
Qualcomm
QCOM
|
+$16.8M |
| 4 |
iShares 10+ Year Investment Grade Corporate Bond ETF
IGLB
|
+$11.3M |
| 5 |
Apple
AAPL
|
+$9.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 20.05% |
| 2 | Financials | 14.05% |
| 3 | Consumer Staples | 12.77% |
| 4 | Technology | 11.27% |
| 5 | Industrials | 9.75% |
Similar funds
Conning's Q2 2019 Portfolio in Review
As of Q2 2019, Conning held 535 positions worth $3.02B, down 5.5% from $3.2B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Conning withdrew a net $373M in Q2 2019, closing 47 positions and reducing 369 holdings. Its most notable exit was Unilever NV New York Registry Shares, an estimated $6.88M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 20% of assets, up from 18% a quarter earlier, followed by Financials and Consumer Staples.
Against the trend, Conning opened a new position in Dow Inc worth $569K.
- Conning's largest Q2 2019 buy was Dow Inc: 11,546 shares worth $569K.
- Conning added most to IBM in Q2 2019, an estimated $35.1M increase.
- Conning's biggest Q2 2019 reduction was AbbVie, cutting an estimated $37.3M.
- Conning fully exited Unilever NV New York Registry Shares in Q2 2019, selling an estimated $6.88M.
- Conning's ten largest holdings make up 17% of its $3.02B portfolio in Q2 2019.
- Conning opened 5 new positions and closed 47 in Q2 2019.
- Conning's portfolio value fell 5.5% quarter-over-quarter to $3.02B.
Based on Conning's 13F filing for Q2 2019, filed 25 Jul 2019.